Dorzolamide Hydrochloride Timolol Maleate
Product Images NDC 70377-082

6 FDA label images from Biocon Pharma Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Dorzolamide Hydrochloride Timolol Maleate (NDC 70377-082). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Biocon Pharma Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carton-label (Carton Label)

Carton-label (Carton Label)
Packaging label for DORZOLAMIDE HCl/Timolol Maleate ophthalmic solution, USP 22.3 mg/6.8 mg per mL, sterile, 10 mL. The label includes usage instructions "For use in the eyes only," manufacturer details for Biocon Pharma Inc. and Indoco Remedies Limited, and storage instructions. The label features a purple and blue color scheme with the Biocon logo and barcode.*
FDA Label Image

Container-label (Container Label)

Container-label (Container Label)
The label for Dorzolamide HCl/Timolol Maleate ophthalmic solution, USP, showing a concentration of 22.3 mg/6.8 mg per mL in a 10 mL bottle. It is labeled for use in the eyes only and marketed by Biocon Pharma Inc. The label includes instructions to protect from light, manufacturing details for Biocon Pharma Inc. and Indoco Remedies Limited, a barcode, lot and expiration date fields, and a Biocon logo.*
FDA Label Image

Dorzo (Dorzo)

Dorzo (Dorzo)
Chemical structure of dorzolamide hydrochloride, showing ring structures, sulfonamide group, and hydrochloride as indicated in the product data for DORZOLAMIDE HYDROCHLORIDE TIMOLOL MALEATE by Biocon Pharma Inc.*
FDA Label Image

Fig-a (Fig A)

Fig-a (Fig A)
An instructional diagram labeled Figure A, showing a person holding an eye dropper near the eye, demonstrating the method to instill eye drops into the lower eyelid. This illustration is related to the use of DORZOLAMIDE HYDROCHLORIDE TIMOLOL MALEATE eye drops.*
FDA Label Image

Fig-b (Fig B)

Fig-b (Fig B)
An instructional illustration showing how to administer eye drops. The image depicts a hand holding an eye drop bottle positioned above an open eye, demonstrating the correct method to apply drops into the eye.*
FDA Label Image

Timo (Timo)

Timo (Timo)
Chemical structure of the active ingredient shown in the image, likely representing components of the combination drug Dorzolamide Hydrochloride and Timolol Maleate by Biocon Pharma Inc. The structure includes ring and chain elements characteristic of these molecules.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.